| [1] |
XU Tingting, WANG Wanjie, BAO Jing, XIA Ruixiang.
The relationship between NLRC4-mediated inflammasome pathway and multiple myeloma and its therapeutic prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 501-508.
|
| [2] |
CHU Yunqian, XUE Ya, JIANG Hua, QI Chunjian, DAI Hanjue, XIAN Qingying, ZHU Wenyu.
Exploratory study of fecal microbiota transplantation combined with immune checkpoint inhibitors in the treatment of end-stage malignant tumor patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 509-516.
|
| [3] |
LU Qi, DU Lili, SUN Jin.
The role of platelets in tumor development and the treatments based on them
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 290-296.
|
| [4] |
CHEN Zhenmei, CHEN Jinhong.
Advances in precision diagnosis and treatment of cholangiocarcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 159-170.
|
| [5] |
LI Qingyun, HUANG Ke.
Etiology, diagnosis, and current treatment of excessive daytime sleepiness
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(12): 1587-1595.
|
| [6] |
LI Nana, LI Zijian.
Advances in the study of acquired FXIII deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1070-1075.
|
| [7] |
CHEN Guihai, DENG Liying, DU Yijie, HUANG Zhili, JIANG Fan, JIN Furui, LI Yanpeng, LIU Chunfeng, PAN Jiyang, PENG Yanhui, SU Changjun, TANG Jiyou, WANG Tao, WANG Zan, WU Huijuan, XUE Rong, YANG Yuechang, YU Fengchun, YU Huan, ZHAN Shuqin, ZHANG Hongju, ZHANG Lin, ZHAO Zhengqing, ZHAO Zhongxin.
Expert consensus on the diagnosis and treatment of insomnia in specified populations
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 841-852.
|
| [8] |
LIU Xuan, FENG Cuijuan, WANG Yiqiang, LI Fang.
Research progress of miRNA in ulcerative colitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 917-929.
|
| [9] |
ZHENG Yunxi, YI Xiaofang, XU Congjian.
Progress in the application of non-peptide gonadotropin-releasing hormone antagonist in the treatment of uterine fibroid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 482-487.
|
| [10] |
QIN Xian, WANG Qian, HOU Jia, XU Dongmei.
Stains: recent research progress for endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 488-494.
|
| [11] |
HUANG Chunzhi, LIU Qinglan, SU Ran, SUN Nan.
Drug treatment options and research progress of adolescent endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 535-542.
|
| [12] |
ZHANG Ting, SUN Rong, YANG Yong, LIU Weichun, YUAN Yuping, JU Xu, WANG Qian.
Mechanism and treatment of mucous hypersecretion in chronic obstructive pulmonary disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 383-391.
|
| [13] |
XIAO Lei, CAO Can, LIU Jiatao.
Analysis of the concentration of digoxin and influential factors for adverse reaction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(11): 1280-1287.
|
| [14] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
| [15] |
WANG Chaoyi, SONG Qiang, XIONG Xin, WANG Mengyuan.
Research progress on diagnosis and treatment of granulomatous lobular mastitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 910-917.
|